Vanguard Group Inc Aurinia Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,531,617 shares of AUPH stock, worth $8.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,531,617
Previous 1,510,498 1.4%
Holding current value
$8.75 Million
Previous $13.6 Million 43.49%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$4.93 - $9.31 $104,116 - $196,617
21,119 Added 1.4%
1,531,617 $7.67 Million
Q4 2023

Mar 11, 2024
BUY
$7.13 - $9.49 $9,532 - $12,688
1,337 Added 0.09%
1,510,498 $13.6 Million
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $177,487 - $236,234
24,893 Added 1.68%
1,509,161 $13.6 Million
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $790,605 - $1.25 Million
101,751 Added 7.36%
1,484,268 $11.5 Million
Q2 2023

Aug 14, 2023
BUY
$8.96 - $11.69 $487,486 - $636,017
54,407 Added 4.1%
1,382,517 $13.4 Million
Q1 2023

May 15, 2023
SELL
$5.94 - $11.27 $275,693 - $523,074
-46,413 Reduced 3.38%
1,328,110 $14.6 Million
Q4 2022

Feb 10, 2023
BUY
$4.11 - $8.14 $686,016 - $1.36 Million
166,914 Added 13.82%
1,374,523 $5.94 Million
Q3 2022

Nov 14, 2022
BUY
$6.66 - $12.39 $257,422 - $478,898
38,652 Added 3.31%
1,207,609 $9.08 Million
Q2 2022

Aug 12, 2022
BUY
$8.95 - $12.8 $5.72 Million - $8.18 Million
638,898 Added 120.53%
1,168,957 $11.7 Million
Q1 2022

May 13, 2022
BUY
$10.05 - $22.48 $1.11 Million - $2.48 Million
110,354 Added 26.29%
530,059 $6.56 Million
Q4 2021

Feb 14, 2022
BUY
$17.78 - $33.08 $6.17 Million - $11.5 Million
347,094 Added 478.02%
419,705 $9.6 Million
Q3 2021

Nov 12, 2021
BUY
$10.93 - $23.55 $819 - $1,766
75 Added 0.1%
72,611 $1.61 Million
Q2 2021

Aug 13, 2021
BUY
$10.0 - $14.52 $725,360 - $1.05 Million
72,536 New
72,536 $940,000

Others Institutions Holding AUPH

# of Institutions
205
Shares Held
55.6M
Call Options Held
838K
Put Options Held
1.18M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $810M
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email